# Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

> **NCT01561027** · PHASE2 · COMPLETED · sponsor: **Biogen** · enrollment: 82 (actual)

## Conditions studied

- Lumbosacral Radiculopathy

## Interventions

- **DRUG:** CNV1014802
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01561027
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-30
- **Primary completion:** 2012-06-30
- **Final completion:** 2012-08-31
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01561027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01561027, "Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01561027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*